Xylem Inc. (NYSE:XYL – Get Free Report) Director D Koch bought 11,000 shares of the stock in a transaction that occurred on Thursday, October 29th. The stock was bought at an average cost of $89.60 per share, for a total transaction of $985,600.00. Following the completion of the purchase, the director directly owned 12,247 shares of the company’s stock, valued at $1,097,331.20. This represents a 882.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Xylem Trading Up 1.8%
Shares of Xylem stock opened at $92.41 on Friday. Xylem Inc. has a 1 year low of $87.40 and a 1 year high of $152.43. The firm has a market cap of $21.19 billion, a PE ratio of 20.44, a PEG ratio of 1.51 and a beta of 1.00. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.39 and a quick ratio of 1.24. The company has a 50 day simple moving average of $105.05 and a two-hundred day simple moving average of $117.57.
Xylem (NYSE:XYL – Get Free Report) last issued its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. Xylem had a return on equity of 12.06% and a net margin of 11.94%. Xylem’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.37 EPS. Analysts expect that Xylem Inc. will post 5.45 earnings per share for the current fiscal year.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Investors of record on Thursday, August 27th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend was Thursday, August 27th. Xylem’s dividend payout ratio is currently 40.95%.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on XYL shares. Mizuho set a $99.00 price target on Xylem in a research note on Wednesday. The Goldman Sachs Group cut their price objective on Xylem from $160.00 to $138.00 and set a “buy” rating for the company in a report on Wednesday. UBS Group reduced their price objective on Xylem from $112.00 to $99.00 and set a “neutral” rating on the stock in a research report on Thursday. Citigroup decreased their price objective on Xylem from $148.00 to $130.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Wolfe Research initiated coverage on Xylem in a research report on Tuesday, September 15th. They issued a “peer perform” rating for the company. Nine equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $121.31.
Check Out Our Latest Analysis on Xylem
More Xylem News
Here are the key news stories impacting Xylem this week:
- Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
- Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
- Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
- Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
- Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
- Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement
Hedge Funds Weigh In On Xylem
A number of large investors have recently added to or reduced their stakes in XYL. BlackRock Inc. purchased a new stake in Xylem during the 2nd quarter valued at $2,959,730,000. State Street Corp increased its position in shares of Xylem by 2.4% in the second quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock valued at $1,352,874,000 after acquiring an additional 270,972 shares during the period. XXEC Inc. purchased a new position in shares of Xylem in the second quarter valued at about $850,841,000. Swedbank AB increased its position in shares of Xylem by 0.3% in the first quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company’s stock valued at $660,444,000 after acquiring an additional 18,759 shares during the period. Finally, Royal Bank of Canada raised its stake in shares of Xylem by 1.1% during the first quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company’s stock valued at $569,207,000 after acquiring an additional 53,210 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.
The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.
Read More
- Five stocks we like better than Xylem
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
